Through cancer trials, doctors hope to find new ways to improve patients’ cancer treatments and quality of life. Clinical trials provide access to innovative and experimental therapies to patients with solid and circulating tumors, including through the National Cancer Institute’s Clinical Trials Network (NCTN). Our centralized clinical research team is comprised of research nurses, data managers, and regulatory coordinators.
Investigative research, provides the ability to identify, develop and study new innovations in a real health system setting. While cancer care has already made tremendous progress, further innovation and research is necessary to develop and implement the next generation of therapeutics, best practices and disease prevention and targeted treatments targeted to the precise needs of the patient.
As part of the AdventHealth Oncology Research program In the Rocky Mountain Region we can access clinical trials that lead to investigational treatments and experiential cancer therapies.
Our research is conducted by our dedicated team of physicians determined to find the effectiveness of a new drugs or technology in a real-world setting. Investigational treatments provide patients with additional treatment options otherwise not available while contributing to cancer research.
4 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
This is a randomized Phase III trial comparing a standard neoadjuvant chemotherapy regimen to an experimental neoadjuvant chemotherapy regimen that omits AC therapy. Both arms receive pembrolizumab...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.
